KM Corporation (KOSDAQ:083550)
3,600.00
-50.00 (-1.37%)
At close: Jan 29, 2026
KM Corporation Revenue
KM Corporation had revenue of 34.53B KRW in the quarter ending September 30, 2025, with 0.84% growth. This brings the company's revenue in the last twelve months to 133.05B, up 1.57% year-over-year. In the year 2024, KM Corporation had annual revenue of 131.14B with 2.63% growth.
Revenue (ttm)
133.05B
Revenue Growth
+1.57%
P/S Ratio
0.34
Revenue / Employee
523.83M
Employees
254
Market Cap
45.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 131.14B | 3.36B | 2.63% |
| Dec 31, 2023 | 127.78B | -23.87B | -15.74% |
| Dec 31, 2022 | 151.65B | 8.40B | 5.87% |
| Dec 31, 2021 | 143.25B | -44.67B | -23.77% |
| Dec 31, 2020 | 187.91B | 60.35B | 47.31% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| JW Shinyak | 76.02B |
| Sewoon Medical | 62.13B |
| CG MedTech | 45.59B |
| OSTEONIC | 42.11B |
| Wonbiogen | 34.38B |
| Billions | 30.71B |
| T&R Biofab | 20.67B |
| SCL Science | 16.32B |